Difficulty: Medium
Average Score: 62%
Practice
Henoch-Sch├Ânlein purpura is the most common small vessel vasculitis in childhood. Aggressive therapy may be reasonable in those with
Correct answer
D
Rationale
Henoch-Sch├Ânlein purpura (HSP) is a vasculitis that primarily affects children. In the context of pediatric GU disorders, the correct answer is D) >50% crescents on renal biopsy. This is because the presence of more than 50% crescents on renal biopsy indicates severe renal involvement and potential progression to renal failure in children with HSP. Aggressive therapy, such as immunosuppressive agents, may be necessary to prevent long-term kidney damage in these cases.
Option A) isolated microscopic hematuria and B) insignificant proteinuria are not indicators for aggressive therapy in HSP. These findings are relatively common in children with HSP and usually resolve spontaneously without long-term consequences.
Option C) severe systemic manifestations, while concerning, do not specifically indicate the need for aggressive therapy in HSP related to renal involvement. Systemic manifestations can be managed symptomatically and may not necessarily correlate with the severity of renal disease in HSP.
In an educational context, understanding the criteria for initiating aggressive therapy in pediatric GU disorders like HSP is crucial for healthcare providers managing these patients. Recognizing the significance of specific renal biopsy findings, such as crescents, can guide treatment decisions and improve outcomes for children with HSP. It is important to differentiate between benign manifestations of HSP and severe renal involvement to provide appropriate care and prevent long-term complications.
Option A) isolated microscopic hematuria and B) insignificant proteinuria are not indicators for aggressive therapy in HSP. These findings are relatively common in children with HSP and usually resolve spontaneously without long-term consequences.
Option C) severe systemic manifestations, while concerning, do not specifically indicate the need for aggressive therapy in HSP related to renal involvement. Systemic manifestations can be managed symptomatically and may not necessarily correlate with the severity of renal disease in HSP.
In an educational context, understanding the criteria for initiating aggressive therapy in pediatric GU disorders like HSP is crucial for healthcare providers managing these patients. Recognizing the significance of specific renal biopsy findings, such as crescents, can guide treatment decisions and improve outcomes for children with HSP. It is important to differentiate between benign manifestations of HSP and severe renal involvement to provide appropriate care and prevent long-term complications.